Tricyclic compounds, including three merging cycles, one sulfur, one tridiazole and one 1,4-diazo, bromide control inhibitors, and pharmaceutical components contribute to the treatment of regulatory disorders of BET family polypeptides, such as tumors and pathogens. Inflammation, metabolic syndrome, obesity, fatty liver, diabetes, heart failure, allergies, etc.
Tricyclic compounds, including three merging cycles, one sulfur, one tridiazole and one 1,4-diazo, bromide control inhibitors, and pharmaceutical components contribute to the treatment of regulatory disorders of BET family polypeptides, such as tumors and pathogens. Inflammation, metabolic syndrome, obesity, fatty liver, diabetes, heart failure, allergies, etc.Compuestos tricíclicos, que contienen tres ciclos fusionados, un tiofeno, un triazol y 1,4-diazepina, inhibidores del bromodominio composición farmacológica útiles en el tratamiento de trastornos con respuesta a la modulación de un polipéptido de la familia BET, tales como neoplasia, enfermedades inflamatorias, síndrome metabólico, obesidad, hígado graso, diabetes, insuficiencia cardíaca, aterosclerosis, entre otras.
